‘Patents can work for or against you. Creating your own patent portfolio, while mitigating the risks of your competitors’ IP rights, is essential for success in today’s technology-based economy.’
Tamara Elmore
- Life Sciences
- European and Dutch Patent Attorney, European Patent Litigator
- United States Patent Agent
- Partner
Tamara Elmore is a Dutch and European patent attorney and a United States patent agent. She started her career at a large pharmaceutical company in Switzerland, before joining an IP office in Boston as a US patent agent. In 2009, she switched to V.O. where she is active as a patent attorney in the Chemistry & Life Sciences Department.
News
T 1186/24: claim wording determines the scope of sufficiency analysis
Claim interpretation can determine whether the invention is sufficiently disclosed In T 1186/24, Technical Board of Appeal 3.3.08, 18 June 2026, the European Patent Office (EPO) considered how the wording of a claim affects the assessment of sufficiency of disclosure. The Board held that an expressly claimed alternative could not be read out of the […]Continue reading
The license of right for the unitary patent: smart cost saving or strategic limitation?
With the introduction of the European patent with unitary effect (unitary patent or UP), patent holders now have access to new strategic tools. One of these is the license of right (LoR). What does such a declaration entail, and what advantages and disadvantages can it have for the protection of your intellectual property?Continue reading
UPC jurisdiction over UK designations and conditional infringement relief in Fujifilm v Kodak
In the case of Kodak vs. Fujifilm concerning EP 3 511 174 on 2 June 2026 before the Court of Appeal of the Unified Patent, the Court of Appeal addressed the UPC’s jurisdiction over the UK designation of a European patent. The decision is important because it applies the CJEU’s reasoning in BSH v Electrolux […]Continue reading